BUY Torrent Pharmaceuticals Limited — Morgan Stanley
byMorgan StanleyHorizon: NA (inferred 1 year)3 Aug 2026via Financial Express Market
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·23 Oct · 2d ago
India Ratings and Research has affirmed the company's credit rating at IND AA+ and revised the outlook from stable to positive for its banking facilities, issuer rating, and non-convertible debentures
BSE · Company Update·7 Oct · 3w ago
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·7 Oct · 3w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·29 Sept · 4w ago
Torrent Pharma Q2 Results: Net profit declines despite 51% revenue growth; misses estimates
NewsCnbc-Tv18·23 Oct · 2d ago
Torrent accepts Kelshikar resignation: October 23 call for Torrent Pharmaceuticals stock
NewsGoogle News·19 Oct · 6d ago
Torrent Pharmaceuticals accepts resignation of Executive Director Amal Kelshikar
NewsGoogle News·16 Oct · 1w ago
Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director?
NewsGoogle News·16 Oct · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Torrent Pharmaceuticals
- BUY — Manas Jaiswal23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY — Prakash Gaba19 Oct 2026 · Same day · target ₹4,680 · SL hit
- SELL — Prakash Gaba7 Oct 2026 · Next day · target ₹4,650 · SL hit
- BUY — HSBC Securities7 Oct 2026 · ~1 year · target ₹5,680 · Active
- BUY — Shrikant Chouhan, Kotak Securities29 Sept 2026 · ~3 months · target ₹5,100 · Active
More from Morgan Stanley
- BUY Eternal22 Oct 2026 · ~1 year · target ₹417 · Active
- BUY Reliance Industries22 Oct 2026 · ~1 year · target ₹1,525 · Active
- SELL SRF22 Oct 2026 · ~1 year · target ₹2,260 · Target hit
- SELL PI Industries21 Oct 2026 · ~1 year · target ₹2,030 · Target hit
- BUY UltraTech Cement21 Oct 2026 · ~1 year · target ₹13,800 · Active

